[Adjuvant chemotherapy for extranodal non-Hodgkin's lymphoma]

Gan To Kagaku Ryoho. 1983 Dec;10(12):2545-9.
[Article in Japanese]

Abstract

From 1976 to 1982, twenty-four cases with early stages (stage IE: 18, Stage IIE: 6) of extranodal non-Hodgkin's lymphomas were treated with combined modality of local treatment (radiation or operation) and an adjuvant chemotherapy consisting of vincristine, cyclophosphamide and prednisolone. Eighty-three percent of patients were diffuse histiocytic type. The most common sites of primary origin were in stomach; 13 patients and 7 patients in nasal or paranasal cavity. The disease-free survival rates at 5 years were 74% for stage IE and 80% for stage IIE, respectively. The result has suggested that adjuvant chemotherapy is a useful modality for extranodal non-Hodgkin's lymphoma.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Female
  • Humans
  • Lymphoma / blood
  • Lymphoma / drug therapy*
  • Lymphoma / mortality
  • Lymphoma / radiotherapy
  • Male
  • Middle Aged
  • Prednisolone / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Cyclophosphamide
  • Prednisolone